Paratek Pharmaceuticals ( NASDAQ:PRTK – Get Rating ) had its target price decreased by HC Wainwright from $10.00 to $6.00 in a research report sent to investors on Wednesday morning, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals' Q2 2023 earnings at ($0.30) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 earnings at ($1.06) EPS, FY2024 earnings at $0.44 EPS, FY2025 earnings at $0.05 EPS, FY2026 earnings at $1.09 EPS and FY2027 earnings at $1.

https://www.dailypolitical.com/2023/05/13/hc-wainwright-trims-paratek-pharmaceuticals-nasdaqprtk-target-price-to-6-00.html

#dailypolitical